Saint Louis University

Running trials

• Recruiting

  Effects of Pistachios on Postprandial Metabolic Responses in Adults With Overweight or Obesity

  NCT07853898· St. Louis University· Source

• Recruiting

  Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study

  NCT07849439· St. Louis University· Source

• Recruiting

  Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe

  NCT06825897· Santiago Ortega Gutierrez· Source

• Recruiting

  A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

  NCT06807281· Phase 3· Pfizer· Source

• Not yet recruiting

  Bariatric Embolization of Arteries for the Treatment of Nonalcoholic Steatohepatitis

  NCT02933554· Keith Pereira, MD:· Source

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

  NCT07116967· Phase 3· Bristol-Myers Squibb· Source

• Active, not recruiting

  A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

  NCT07076199· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

  NCT06807268· Phase 3· Pfizer· Source

• Active, not recruiting

  64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer

  NCT06970847· Phase 3· Clarity Pharmaceuticals Ltd· Source

• Recruiting

  Lead-212 PSV359 Therapy for Patients With Solid Tumors

  NCT06710756· Phase 1/2· Perspective Therapeutics· Source

• Recruiting

  Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease

  NCT06859528· St. Louis University· Source

• Active, not recruiting

  A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

  NCT06345339· Phase 2/3· AbbVie· Source

• Recruiting

  An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

  NCT05939414· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)

  NCT05818150· Merit Medical Systems, Inc.· Source

• Recruiting

  SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

  NCT06001827· VenoStent· Source

• Recruiting

  The Fourth Left Atrial Appendage Occlusion Study

  NCT05963698· Hamilton Health Sciences Corporation· Source

• Active, not recruiting

  Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure

  NCT05598333· Phase 2· AskBio Inc· Source

• Enrolling by invitation

  An Open-label Study of XEN1101 in Epilepsy

  NCT05718817· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Recruiting

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  NCT05667142· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Active, not recruiting

  A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

  NCT05531565· Phase 2/3· Biogen· Source

• Active, not recruiting

  Colorectal Cancer Screening in Cystic Fibrosis

  NCT05362344· University of Washington, the Collaborative Health Studies Coordinating Center· Source

• Active, not recruiting

  A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

  NCT05500222· Phase 3· Madrigal Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

  NCT05142696· Phase 1/2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

  NCT05064553· Exact Sciences Corporation· Source

• Active, not recruiting

  An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

  NCT04720157· Phase 3· Novartis Pharmaceuticals· Source

• Recruiting

  Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

  NCT04634240· University of British Columbia· Source

• Active, not recruiting

  Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

  NCT04526665· Phase 3· Ipsen· Source

• Recruiting

  Mindfulness in Endometrial and Cervical Cancer

  NCT04512144· St. Louis University· Source

• Active, not recruiting

  HEALEY ALS Platform Trial - Master Protocol

  NCT04297683· Phase 2/3· Merit E. Cudkowicz, MD· Source

• Active, not recruiting

  A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

  NCT03767244· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

  NCT03900429· Phase 3· Madrigal Pharmaceuticals, Inc.· Source

• Recruiting

  Post-Op Pain Control for Prophylactic Intramedullary Nailing.

  NCT03823534· Phase 3· St. Louis University· Source

• Active, not recruiting

  A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

  NCT03105102· Phase 3· AbbVie· Source

• Active, not recruiting

  Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

  NCT03301506· Phase 3· Gilead Sciences· Source

• Active, not recruiting

  A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

  NCT03251118· Target PharmaSolutions, Inc.· Source

• Active, not recruiting

  Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

  NCT03108456· Abbott Medical Devices· Source

• Active, not recruiting

  A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

  NCT02954094· Target PharmaSolutions, Inc.· Source

• Recruiting

  Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

  NCT03013998· Phase 2/3· Beat AML, LLC· Source

• Active, not recruiting

  Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

  NCT02864992· Phase 2· EMD Serono Research & Development Institute, Inc.· Source

• Recruiting

  ALS/MND Natural History Study Data Repository

  NCT05966038· Massachusetts General Hospital· Source

• Active, not recruiting

  Alpha-1 Antitrypsin Deficiency Adult Liver Study

  NCT02014415· St. Louis University· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Epilepsy2 recruiting
• Stroke2 recruiting
• Acute myeloid leukaemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• Amyloidosis1 recruiting
• Aortic stenosis1 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Atrial fibrillation1 recruiting
• Cervical cancer1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Endometrial cancer1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• Mesothelioma1 recruiting
• Multiple myeloma1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Parkinson disease1 recruiting
• Prostate cancer1 recruiting
• Psoriasis1 recruiting
• Sarcoma1 recruiting

Closed trials

• Completed

  A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05704738· Phase 3· Amgen· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

  NCT05769608· Phase 2· Mineralys Therapeutics Inc.· Source

• Completed

  Vitamin E Dosing Study

  NCT04801849· Phase 2· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· Source

• Completed

  Effect of Exercise on Biomarkers in SCT

  NCT04273022· St. Louis University· Source

• Completed

  Integration of Hypertension Management Into HIV Care in Nigeria

  NCT04704336· NYU Langone Health· Source

• Completed

  A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)

  NCT04813926· Bayer· Source

• Completed

  Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia

  NCT04864795· Vifor (International) Inc.· Source

• Completed

  Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

  NCT04454463· Johns Hopkins Bloomberg School of Public Health· Source

• Completed

  Gyn Onc Prehab Study

  NCT04298827· St. Louis University· Source

• Completed

  ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease

  NCT03622905· Functional Neuromodulation Ltd· Source

• Completed

  The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

  NCT03805308· Mercy Health Ohio· Source

• Completed

  A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms

  NCT03642639· Cerenovus, Part of DePuy Synthes Products, Inc.· Source

• Completed

  A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

  NCT02932449· Target PharmaSolutions, Inc.· Source

• Completed

  Characteristics of Patient Population With Endometriosis

  NCT03002870· St. Louis University· Source

• Completed

  A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

  NCT02815891· Target PharmaSolutions, Inc.· Source

• Recruiting

  Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

  NCT02418442· Duke University· Source

• Completed

  A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

  NCT01848561· AbbVie· Source

• Completed

  Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

  NCT01064440· Phase 2· Helixmith Co., Ltd.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Primary biliary cholangitis9 works · 3 trials
• Frontotemporal dementia8 works · 0 trials
• Gastroparesis4 works · 0 trials
• Vascular dementia4 works · 0 trials